Background. The development of breast lymphedema (BLE) after breast/axillary surgery is poorly characterized. We prospectively evaluated clinical and surgical factors associated with development of BLE. Methods. Patients undergoing unilateral breast-conserving surgery were prospectively enrolled preoperatively and followed for development of BLE. To augment the number of patients with BLE for evaluation of risk factors, postoperative patients identified in the clinic with signs and symptoms of BLE were also enrolled. Logistic regression with Firth's penalized likelihood bias-reduction method was used for univariate and multivariate analysis. Results. Of 144 women, 124 were enrolled preoperatively (38 of whom developed BLE), and 20 women with BLE were enrolled postoperatively. Any type of axillary surgery was the strongest factor associated with BLE (odds ratio, 134; 95 % confidence interval, 18 to [1,000). All 58 BLE events occurred in women with axillary surgery as compared with no events in the 46 patients without axillary surgery (p \ 0.0001). Among 98 women who underwent axillary surgery, BLE did not occur more often after axillary lymph node dissection versus sentinel lymph node biopsy (p = 0.38) and was not associated with total number of nodes removed (p = 0.52). In multivariate analysis, factors associated with the development of BLE in the axillary surgery subgroup included baseline BMI (p = 0.004), incision location (p = 0.009), and prior surgical biopsy (p = 0.01). Conclusions. Risk of BLE is primarily related to performance of any axillary surgery but not the extent of axillary surgery or number of lymph nodes removed. Other factors associated with BLE were increased body mass index, incision location, and prior surgical excisional biopsy.
ABSTRACT
Background. The development of breast lymphedema (BLE) after breast/axillary surgery is poorly characterized. We prospectively evaluated clinical and surgical factors associated with development of BLE. Methods. Patients undergoing unilateral breast-conserving surgery were prospectively enrolled preoperatively and followed for development of BLE. To augment the number of patients with BLE for evaluation of risk factors, postoperative patients identified in the clinic with signs and symptoms of BLE were also enrolled. Logistic regression with Firth's penalized likelihood bias-reduction method was used for univariate and multivariate analysis. Results. Of 144 women, 124 were enrolled preoperatively (38 of whom developed BLE), and 20 women with BLE were enrolled postoperatively. Any type of axillary surgery was the strongest factor associated with BLE (odds ratio, 134; 95 % confidence interval, 18 to [1,000). All 58 BLE events occurred in women with axillary surgery as compared with no events in the 46 patients without axillary surgery (p \ 0.0001). Among 98 women who underwent axillary surgery, BLE did not occur more often after axillary lymph node dissection versus sentinel lymph node biopsy (p = 0.38) and was not associated with total number of nodes removed (p = 0.52). In multivariate analysis, factors associated with the development of BLE in the axillary surgery subgroup included baseline BMI (p = 0.004), incision location (p = 0.009), and prior surgical biopsy (p = 0.01). Conclusions. Risk of BLE is primarily related to performance of any axillary surgery but not the extent of axillary surgery or number of lymph nodes removed. Other factors associated with BLE were increased body mass index, incision location, and prior surgical excisional biopsy.
Breast cancer-related lymphedema is a well-known sequela of surgery and adjuvant therapy for the treatment of breast cancer. The majority of patients and physicians, when thinking about lymphedema related to breast cancer treatment, consider lymphedema of the arm; however, breast cancer patients can develop lymphedema in other regions, including the chest wall and the breast. [1] [2] [3] [4] Breast lymphedema (BLE) has not received as much attention by physicians and patients and has been understudied because it has been more challenging to quantify. Patients who undergo any breast surgery, in particular, those undergoing breast-conservation surgery for breast cancer, are at a theoretically increased risk of developing BLE because of the surgical incision and tissue dissection with potential disruption of lymphatic drainage of the breast.
BLE is characterized by diffuse skin edema and erythema as well as self-reported symptoms including breast heaviness, redness, and swelling. 4 In a prospective study evaluating the incidence of BLE, our group demonstrated that 31 % of women undergoing breast surgery develop BLE.
In this article, we further evaluate the clinical and surgical risk factors associated with the development of BLE after breast surgery. Because, anecdotally, early BLE intervention may render the natural history of BLE more benign and less degrading to quality of life, we believe that there may be value in identifying variables that enhance our ability to accurately risk-stratify patients with regard to the development of BLE.
METHODS
A prospective clinical study enrolled women undergoing unilateral nonmastectomy breast surgery to study the postoperative complication of BLE. Women were enrolled from the breast surgical practice from September 2006 to February 2009. The study population, methods, and interrater agreement for the BLE diagnosis were previously described in detail. 4 Briefly, patients were evaluated preoperatively and at 1, 3, 6, and 12 months after surgery for the development of BLE. Each patient was evaluated for the development of BLE at each follow-up visit on the basis of a graded physical examination that focused on clinical signs of edema and erythema performed by one of two registered nurses on the study team; interobserver reproducibility between the nurse assessments and surgeon and lymphedema physicians has been previously reported. 4 A patient was classified as having BLE if a clinical impression of BLE was present at 2 or more visits beyond 1 month after surgery or a clinical impression of BLE was present at one visit greater than 1 month after surgery with either moderate or severe edema or erythema. Risk factor data were collected prospectively and entered into a study database.
To increase the number of women with BLE available for assessment, 20 additional patients were enrolled who had BLE that was identified postoperatively. These patients met the same criteria as patients enrolled preoperatively, and their risk factor data were collected retrospectively from medical records by using the same definitions as for the prospective cohort.
Statistical Methods
Univariate associations between potential risk factors and the development of BLE were examined by using logistic regression to estimate profile-likelihood p-values, odds ratios (ORs), and 95 % profile-likelihood confidence intervals (CIs). The Firth penalized likelihood bias-reduction method was used because of sparse data, including complete data separation for some categorical variables. 5 For ordinal variables, such as TNM stage and bra cup size, the reported p-value is for a linear trend across categories. Logistic regression was also used to perform multivariate analysis. p-Values \0.05 were considered statistically significant. Analysis was performed with SAS (Version 9.2, SAS Institute Inc.) and the logistf package for R (Version 2.15). 6 
RESULTS
A total of 144 women who underwent breast surgery were included in the study. These included 124 women enrolled preoperatively (38 of whom developed BLE during follow-up) and 20 women with BLE enrolled during their postoperative course. Overall, 58 women with BLE and 86 without BLE were available for evaluation of risk factors. Baseline and surgical characteristics are summarized in Table 1 . The median length of postsurgical followup for BLE was 11 months (range, 3-68 months).
Effect of Axillary Surgery
Of the 144 patients, 98 underwent axillary surgery [79 sentinel lymph node biopsy (SLNB) and 19 axillary lymph node dissection (ALND)], and 46 did not [32 excisional biopsy and 14 wide local excision (WLE) only]. All 58 of the BLE events were observed in patients with axillary surgery (45 WLE?SLNB and 13 WLE?ALND), and 0 of 46 (95 % CI 0-7.7 %) of patients without axillary surgery developed BLE. Because none of the 46 patients without an axillary procedure developed BLE, axillary surgery was by far the most influential risk factor (OR 134; 95 % CI, 18 to [1,000; p \ 0.0001). This remained true with only slight attenuation (adjusted OR 118; 95 % CI 14 to[1,000; p \ 0.0001) after adjustment for age, body mass index (BMI), total specimen volume, scar length, incision location, smoking, and prior surgical biopsy. Because of these findings, we believed that it was most relevant to evaluate additional risk factors for BLE in the subgroup of patients who had any type of axillary surgery.
Risk Factors in the Axillary Surgery Subgroup
Patient, cancer, and surgery characteristics are summarized by outcome group with univariate ORs in Table 2 for patients who underwent an axillary procedure (SLNB and/ or ALND). Among patients with BLE, 22 % had an ALND as compared with 15 % among those without BLE; this corresponds to an OR of 1.58 for ALND versus SLNB, which was not statistically significant (p = 0.38). Similarly, the number of nodes removed was similar in those who did and did not develop BLE, with a median of 3 nodes in each group and a nonsignificant OR for the number of nodes (OR 0.98 per 1-node increase; p = 0.52).
The variables BMI (p = 0.02), bra cup size (p = 0.04), and breast radius (p = 0.049) were each significantly associated with BLE in univariate analysis. The mean BMI was 31 in patients with BLE as compared with 28 in those without BLE, and the OR was 1.56 per one-unit increase in BMI. Examined as BMI categories, the odds of BLE were two to threefold higher in patients classified as obese (BMI 30-34) or morbidly obese (BMI C35) relative to those with BMI \25. Only 7 women with a bra cup size larger than D were included in the study, but all 7 developed BLE (OR 9.0 relative to bra cup size A). Similarly, the mean breast radius was larger in those who developed BLE versus not (8.4 vs. 7.6 cm, respectively), for an OR of 1.23 per 1 cm increase. Only six women had a surgical biopsy for diagnosis in the operated breast, and all 6 developed BLE (OR 10.0 relative to needle biopsy; p = 0.04).
The most common incision location was the upper outer quadrant (55 of 98; 56 %). Overall, the location of the breast surgical incision was significant (p = 0.03), with upper outer quadrant, lower inner quadrant, and central locations each showing increased odds relative to lower outer quadrant, which had the lowest risk of BLE. The upper inner quadrant showed a non-significant increase in odds (OR 1.7) relative to lower outer quadrant. The orientation of a scar (radial, antiradial, or circumareolar) was not associated with BLE. There was no difference in BLE rates by surgeon performing the procedure.
Scars were slightly longer (median, 4.8 cm) in women who developed BLE as compared with those who did not develop BLE (4.1 cm); however, this difference did not reach statistical significance (p = 0.21). Similarly, volume of tissue resected was slightly higher in patients who developed BLE (median, 49.5 cm 3 ) than in those who did not develop BLE (45.4 cm 3 ), but this was not significantly different (p = 0.26). Tumor size and TNM stage were not associated with BLE. Four patients with N3 disease developed BLE, resulting in an OR of 5 for this category relative to N0 invasive cancer, but the result was not significant with this small number of patients.
Two patients had congestive heart failure, and both developed BLE, whereas three of four patients with prior midline sternotomy developed BLE, and both patients with insulin-dependent diabetes developed BLE. There was no difference in use of antihypertensive medications between the two groups (40 % in each group; p = 0.97). Of the patients who developed BLE, 24 % (14 patients) were taking diuretic medications, compared with 15 % (6 patients) in the group without BLE (p = 0.29).
Ninety-eight percent of patients received adjuvant radiation, 40 % received adjuvant chemotherapy, and 71 % received adjuvant endocrine therapy. Seven patients (7 %) underwent neoadjuvant chemotherapy. None of these variables was significantly associated with BLE; however, because almost all patients received adjuvant radiotherapy, our ability to evaluate this potential risk factor was limited. 
Multivariate Analysis
BMI, breast radius, and bra cup size were moderately correlated (r = 0.40-0.66) with each other, and although each was significant by univariate analysis for association with BLE, they were no longer significant when included together in a multivariate model, thus suggesting some degree of multicollinearity. BMI was the strongest univariate predictor and was therefore the one retained for the multivariate model. The final multivariate model (Table 3) included the variables BMI, prior surgical biopsy, and incision location, each of which was significant at the 0.05 level in both univariate and multivariate analysis. Additionally, we included the extent of axillary surgery (ALND vs. SLNB) to confirm that this variable remained nonsignificant after adjustment for potential confounding variables (p = 0.84). The c-statistic for this model as a measure of its ability to discriminate between those with and without BLE was 0.78.
In a sensitivity analysis, we excluded the 20 patients with BLE who were enrolled postoperatively with symptomatic BLE, because they may represent a different patient population than the preoperative enrollees. The multivariate analysis results were very similar when only the preoperative enrollees (n = 38 with BLE and n = 40 without BLE) were included; specifically, BMI and prior surgical biopsy remained significant, as did the comparison between central and lower outer quadrant incision location. The effects for upper outer quadrant and lower inner quadrant incision locations were each somewhat attenuated and no longer significant in this subset; however, the ORs continued to show clinically important effects sizes, at 3.0 and 5.8 versus the left outer quadrant, respectively. Again, the extent of axillary surgery was nonsignificant but actually showed slightly lower odds for ALND versus SLNB in this subset (OR 0.66).
DISCUSSION
In this study, we show that axillary surgery is the primary risk factor associated with BLE after lumpectomy and axillary staging surgery. However, other contributing risk factors include BMI, surgical excisional biopsy for diagnosis, and location of the surgical incision, which were each significantly associated with the development of BLE in univariate and multivariate analysis.
BLE usually presents in the first few months after breast surgery. Signs of BLE include diffuse skin edema and erythema. [2] [3] [4] Symptoms of BLE include breast heaviness, redness, and swelling. The overall symptom-associated distress is low; however, in a low proportion of cases, BLE can develop into a chronic distressing condition. Recognizing BLE and differentiating it from breast cellulitis is important to avoid unnecessary use of antibiotics and to initiate early lymphedema treatment to improve lymphatic drainage of the breast. 7 Risk of infection and impaired wound healing is markedly increased in lymphedematous tissues. 8, 9 An understanding of the clinical and surgical risk factors associated with BLE may enable surgeons to mitigate BLE incidence and severity by identifying patients at increased risk for BLE and providing proactive education and treatment. Of the three risk factors identified in our study, using percutaneous biopsy to diagnose breast lesions is already widely recommended for many other reasons. 10 Percutaneous biopsy allows the tumor excision and nodal surgery to be performed at the first operation; in contrast, a diagnostic surgical biopsy followed by an oncologic procedure requires at least two operations. 11 When lumpectomy is performed with a known cancer diagnosis, it facilitates a higher rate of negative margins. 11 Additionally, this study suggests that BLE increases with use of surgical excisional biopsy for diagnosis. The American Society of Breast Surgeons has advocated for use of percutaneous biopsy for diagnosis and considers this a quality measure for breast surgery. 12 For women with higher BMI and/or with larger breast size, appreciable weight loss before cancer surgery is not feasible. However, for women identified to be at increased risk for BLE on the basis of high BMI, patient counseling regarding potential risk of BLE can be considered to allow for the early identification of BLE and the timely initiation of therapy. Body weight and increased BMI are established risk factors for development of arm lymphedema, and a previous study has also shown that the risk of BLE is increased in obese patients. 13, 14 In the present study, each of the variables BMI, breast radius, and bra cup size was univariately significant, but they were generally not significant if included together in a multivariate model, and thus only BMI was retained in our final multivariate model. However, with a larger sample size and, particularly, more women in the category of bra cup size larger than D, which showed a univariate OR of 9.0, we may have been able to elucidate a role for breast size separate from BMI.
In the majority of cases, incision location is affected by tumor location and is not a risk factor that can be easily adjusted. This study, similar to two previous studies, showed that location of tumor in the upper outer quadrant predisposes to BLE; however, we also found that central location and lower inner quadrant also predispose to BLE.
14,15 A possible explanation is that incisions in the central and upper outer quadrant are more disruptive to the main breast lymphatics, as reflected in the increased BLE rates. Our finding contrasts with that of one other study in which tumor location did not influence the prevalence of BLE. 3 In our study group, the largest risk factor associated with the development of BLE was axillary surgery. None of our patients without axillary surgery developed BLE, thus suggesting that the risk of BLE in patients undergoing a breast only operation is small. Therefore, we limited the analysis of additional risk factors to women undergoing axillary surgery as the most relevant subgroup. It is noteworthy that the extent of axillary surgery, including SLNB versus ALND and the absolute number of axillary nodes resected, was not associated with BLE. This is in contrast to arm lymphedema, for which the extent of the axillary surgery has been shown to affect risk. 13 Our findings are consistent with those in the report by Goffman et al., who performed a retrospective study of arm lymphedema and BLE and found that the number of nodes resected was significant for the development of arm lymphedema, but not for BLE. 16 These findings support a theory that SLNB disrupts the primary lymphatic drainage of the breast, and, therefore, BLE risk is similar between SLNB and ALND; SLNB does not necessarily disrupt the primary lymphatic drainage of the arm. However, other studies have reported that BLE rates are higher after ALND than axillary sampling. 2, 3 Limitations of this study include the lack of an objective measurement criterion for BLE. We believe that requiring clinical signs of BLE at more than 1 time point by one of two nurse specialists provided a reliable definition of BLE. Further work is under way evaluating skin thickness on ultrasonography and bioimpedance to be able to better define BLE in the future. Additionally, we were unable to evaluate the effect of radiation as a risk factor, because the vast majority (98 %) of our patients received adjuvant radiation. In a prior study, BLE rates in women undergoing WLE and ALND varied with radiation use, with BLE rates of 5 % in nonradiated patients and 21 % in patients who received adjuvant radiation. 17 Our data collection included information only on recent surgical breast biopsies that were part of the episode of care for this study; data on remote prior breast biopsies could have shed further light on their role in the development of BLE. Additionally, although this is the largest study of its kind to evaluate risk factors of BLE, the modest sample size was insufficient to evaluate uncommon risk factors such as smoking and diabetes.
In conclusion, axillary surgery is the strongest risk factor associated with the development of BLE after breast surgery. However, the extent of axillary surgery (ALND vs. SLNB) and the number of lymph nodes removed were not significantly associated with BLE. Increased BMI, incision location of upper outer quadrant, central location, or lower inner quadrant, and prior surgical biopsy were significantly associated with BLE.
